A Medical Device Daily
Cordis (Miami) reported the appointment of David Kandzari, MD, to the position of Chief Medical Officer, effective early December. In this newly created role, Kandzari will oversee the clinical and medical affairs activities for the cardiology division of Cordis.
Kandzari said that Cordis “has been at the forefront of breakthrough clinical development and, as a physician, I share the company’s mission to defeat cardiovascular disease.” Kandzari was most recently the John Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences and Assistant Professor of Medicine and Molecular Genetics and Microbiology at the Duke University Medical Center (Durham, North Carolina).
He is the author of numerous journal articles in the area of cardiovascular disease and is the recipient of many academic society honors. In 2003, he received the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award. Kandzari has lectured on a range of cardiology topics at conferences throughout the U.S. and abroad.
Cordis, a business of Johnson & Johnson (New Brunswick, New Jersey) is focused on the development of interventional vascular technology.